Pentixapharm Holding AG annual revenue
2021
2022
2023
2024
2025
Pentixapharm Holding AG Revenue Growth & History (PTP)
Pentixapharm Holding AG reported €90,000 in revenue for fiscal 2025, a decrease of 25.00% from the previous fiscal year.
View full Pentixapharm Holding AG company overviewPentixapharm Holding AG annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €90,000 | −€30,000 | −25.00% |
| 2024 | 2024-12-31 | €120,000 | €100,000 | +500.00% |
| 2023 | 2023-12-31 | €20,000 | −€10,000 | −33.33% |
| 2022 | 2022-12-31 | €30,000 | −€30,000 | −50.00% |
| 2021 | 2021-12-31 | €60,000 | — | — |
Pentixapharm Holding AG quarterly revenue
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €0 | −€19,000 | −100.00% |
| Q1 2026 | 2026-03-31 | €0 | −€19,000 | −100.00% |
| Q4 2025 | 2025-12-31 | −€24,000 | — | — |
| Q3 2025 | 2025-09-30 | €79,000 | — | — |
| Q2 2025 | 2025-06-30 | €19,000 | — | — |
| Q1 2025 | 2025-03-31 | €19,000 | — | — |
Pentixapharm Holding AG revenue growth trends
Pentixapharm Holding AG's latest reported quarter, Q2 2026, generated €0 in revenue, a decrease of 100.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Pentixapharm Holding AG source filings ↗